Clinical Interpretation

IMMEDIATE PRIORITIES (Stabilization)

1. ABC + Oxygen First

• SpO2 94% is at the lower acceptable limit for a child with EF 30%. Start supplemental oxygen via nasal cannula or face mask to target SpO2 ≥ 95-98%.
• Position child upright (sitting, legs dependent) to reduce preload if pulmonary congestion is present.

2. Secure IV Access + Monitoring

• Continuous cardiac monitoring (ECG rhythm strip)
• Pulse oximetry continuous
• 12-lead ECG to assess the arrhythmia (HR 50-155 is suspicious for atrial flutter with variable block, or a tachycardia-bradycardia pattern)

3. Stabilize the Heart Rate/Rhythm

• The HR range of 50-155 must be clarified on 12-lead ECG:
  • If tachycardia-induced cardiomyopathy is present (sustained tachycardia causing EF 30%), rate control or rhythm conversion is a priority
  • Tachycardia (HR 155): may worsen the already depressed EF; investigate and treat cause
  • Bradycardia (HR 50): in a 6-year-old with EF 30%, HR <60 is concerning - rule out complete heart block

DIAGNOSTIC WORKUP (Do in Parallel)

MANAGEMENT STRATEGY

A. Treat the Reversible Cause First

• Hypothyroidism is a known and reversible cause of HF with reduced EF - it depresses contractility, causes bradycardia, and can cause pericardial effusion. Per Harrison's Principles of Internal Medicine 22E, "hypothyroidism...commonly exacerbates heart failure" and LV function can improve significantly with thyroid hormone replacement.
• If TSH is elevated: start levothyroxine cautiously (low dose, titrate slowly) - rapid correction can precipitate arrhythmia in a failing heart.

B. Heart Failure with Reduced EF (HFrEF) - Pediatric Protocol

• Furosemide IV/oral - if signs of fluid overload are present (crackles, hepatomegaly, edema)
• Start low: 1 mg/kg IV, monitor urine output

• Enalapril or captopril (Class I, LOE B)
• Reduces afterload, prevents HF progression
• Start low dose once hemodynamically stable

• Spironolactone (Class I, LOE C) - shown to reduce mortality 30% in HFrEF
• Add to ACEi + diuretic regimen

• Carvedilol is the preferred beta-blocker in pediatric HFrEF
• Do NOT start if patient is in acute decompensation or has hemodynamically significant bradycardia (HR 50)
• Initiate only after euvolemia is achieved

• Can be considered in children with LV systolic dysfunction and tachycardia
• Provides mild inotropy + rate control
• Use with caution; check electrolytes first

C. If Acutely Decompensated (low perfusion signs - cold extremities, oliguria, altered mental status):

• Consider dobutamine infusion (2.5-10 mcg/kg/min) as inotropic support
• ICU admission - per ISHLT guidelines, children hospitalized with acute HF should be initially observed in an ICU setting (Class I)

REFERRAL AND ESCALATION

• Pediatric cardiology consultation - urgent/emergent depending on current status
• Endocrinology for thyroid management
• If EF does not improve with optimal medical therapy and thyroid correction: refer for advanced HF evaluation (transplant assessment, mechanical circulatory support)

SUMMARY - Priority Action List

1. Oxygen now (target SpO2 ≥95%)
2. IV access + continuous ECG monitoring
3. 12-lead ECG - characterize the 50-155 HR range
4. Urgent bloods: TSH, BNP, electrolytes, BMP, CBC
5. Echocardiogram to reassess EF and structure
6. Furosemide if signs of congestion/pulmonary edema
7. Pediatric cardiology consult - urgent
8. Treat hypothyroidism if confirmed (levothyroxine slowly)
9. ACEi + spironolactone once stable (not in acute shock)
10. ICU level monitoring given EF 30% + arrhythmia in a 6-year-old

Important note: The HR range of 50-155 in the same patient is unusual and must be clarified - this could represent documentation of different time points, or a genuine arrhythmia (flutter with variable block, tachycardia-bradycardia). Do NOT use negative chronotropes (beta-blockers, non-DHP CCBs) until the bradycardia episodes are explained.